AbbVie claimed FDA approval for its JAK inhibitor Rinvoq (upadacitinib) for rheumatoid arthritis on Friday, setting its price just a little below that of its antibody blockbuster Humira.
>> good morning everyone. welcome to cnn this morning. it is saturday, march 8th 2025 i'm omar jimenez in atlanta. victor blackwell has the day off. we're going to start with new reports about a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback